CANDEL THERAPEUTICS INC (CADL:NASDAQ)

$13.07 -0.68 (-4.9455%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 87

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CANDEL THERAPEUTICS INC (CADL:NASDAQ) News Sources

Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight

26-08-2026

yahoo.com

Candel Therapeutics Announces Publication in The Lancet Oncology of Pivotal Phase 3 Data Demonstrating Significant Improvement in Disease-Free Survival with Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer

02-06-2026

yahoo.com

CADL Stock Heads For Best Week In A Month – Here’s Why Retail Is Bullish

05-06-2026

stocktwits.com

Candel Therapeutics Designates Mark Sims as CCO

25-06-2026

yahoo.com

CADL Stock Heads For Biggest Monthly Gains Since December 2024 – Retail Says ‘Our SLS Days Are Coming’

30-06-2026

stocktwits.com

Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026

03-08-2026

yahoo.com

Candel Therapeutics Eyes 2026 Prostate Cancer Filing as Lung Study Ramps Up

12-08-2026

marketbeat.com

CADL Stock In Focus As Candel Nears Year-End BLA Filing For Prostate Cancer Drug — Eyes $10–$16B Opportunity

12-08-2026

stocktwits.com

CADL Rises As Biotech Eyes First Commercial Product in 2027 — CEO Points To ‘Meaningful Execution’ Toward BLA Submission In Q4

13-08-2026

stocktwits.com

Candel Therapeutics to Present at September Investor Conferences

26-08-2026

yahoo.com

CANDEL THERAPEUTICS INC (CADL:NASDAQ) Sentiment Trend

0 25 50 75 100 89 76 91 83 93 81 91 91 91 90 26-08-2026 02-06-2026 05-06-2026 25-06-2026 30-06-2026 03-08-2026 12-08-2026 13-08-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CANDEL THERAPEUTICS INC (CADL:NASDAQ) FAQs

toggle

What is the current price of CANDEL THERAPEUTICS INC (CADL:NASDAQ)?

The current price of CANDEL THERAPEUTICS INC (CADL:NASDAQ) is $13.07.


toggle

CANDEL THERAPEUTICS INC (CADL:NASDAQ) absolute price change since previous trading day?

The absolute price change of CANDEL THERAPEUTICS INC (CADL:NASDAQ) since the previous trading day is $-0.68.


toggle

CANDEL THERAPEUTICS INC (CADL:NASDAQ) percentage price change since previous trading day?

The percentage price change of CANDEL THERAPEUTICS INC (CADL:NASDAQ) since the previous trading day is -4.9455%.


toggle

What is the most recent average sentiment score for CANDEL THERAPEUTICS INC (CADL:NASDAQ)?

The most recent average sentiment score for CANDEL THERAPEUTICS INC (CADL:NASDAQ) is 87 out of 100.


toggle

What is the most recent average sentiment for CANDEL THERAPEUTICS INC (CADL:NASDAQ)?

The most recent sentiment for CANDEL THERAPEUTICS INC (CADL:NASDAQ) is .


SEC-8K** Filing Available For CANDEL THERAPEUTICS INC (CADL:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.